Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Suspected parental gonadal/gonadosomatic mosaicism for a TINF2 mutation in two sisters with dyskeratosis congenita.

Frontiers in genetics·2026

Same author

A prospective observational cohort study comparing perioperative outcomes, complications, and quality of life between surgical procedures for female stress urinary incontinence.

BMC surgery·2026

Same author

Phase measurement and compensation method for a waveguide beam based on an on-chip 90° optical hybrid mixer.

Optics express·2026

Same author

Knowledge, attitudes, and practices among guardians toward inherited retinal diseases: a structural equation modeling analysis.

Scientific reports·2026

Same author

Two Novel PKLR Variants in Pyruvate Kinase Deficiency: Insights From Clinical, Molecular and Functional Analysis.

International journal of laboratory hematology·2026

Same author

The relationship between psychological resilience and learning engagement of college students: A moderated mediation model.

Acta psychologica·2026

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Novel Machine Learning Approaches Revolutionize Pancreatic Malignancy Prognosis: Exploring Programed Cell Death.

Na Xu¹, Xiaye Miao², Jiali Jiang²

¹Department of Geriatrics, Zhangjiagang Hospital Affiliated to Soochow University, Suzhou, China.

Mediators of Inflammation

|November 10, 2025

Summary

Programed cell death (PCD) mechanisms are crucial in pancreatic ductal adenocarcinoma (PDAC). A novel PCD-based molecular signature accurately predicts patient prognosis, outperforming traditional methods.

Keywords:

machine learning pancreatic ductal adenocarcinoma prognostication programed cell demise tumor microenvironment

More Related Videos

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jul 9, 2026

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

Oncology
Molecular Biology
Immunology

Background:

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options.
Understanding the role of programmed cell death (PCD) pathways is critical for improving PDAC outcomes.

Purpose of the Study:

To explore the role of 18 distinct PCD pathways in PDAC development.
To develop and validate a novel PCD-based molecular signature for prognostic prediction in PDAC.
To investigate the tumor immune microenvironment (TME) alterations associated with high-risk PDAC patients.

Main Methods:

Utilized a machine learning framework with 429 algorithmic variations to develop a PCD-based molecular signature.
Performed integrated pathway analysis to identify oncogenic and immune TME alterations.
Conducted single-cell expression profiling using the TISCH database to analyze gene expression within the TME.

Main Results:

Developed a robust PCD-based molecular signature with superior prognostic capabilities compared to clinicopathological indicators.
Identified distinct oncogenic pathway activation and TME alterations in high-risk PDAC patients, including reduced cytotoxic T lymphocyte infiltration and increased regulatory T cells (Tregs).
Uncovered cell-type-specific expression patterns of PCD-related genes within the TME.

Conclusions:

Programmed cell death (PCD) plays a critical role in PDAC progression.
The novel PCD-based molecular signature offers a promising tool for clinical risk stratification of PDAC patients.
Integrated transcriptomic analyses validate the signature and reveal potential cellular targets for personalized therapeutic strategies to improve PDAC patient outcomes.